Navigation Links
Dendreon Reports PROVENGE Regulatory and Commercialization Progress and Future Pipeline Plans at Analyst Event
Date:9/24/2009

first half of 2011.
  • Dendreon recently signed leases for additional manufacturing facilities in Los Angeles and Atlanta. Both are expected to have 36 workstations, and additional capacity from these facilities will be available in the second half of 2011.
  • Dendreon will leverage established third parties for patient/physician scheduling, apheresis and product transportation. Dendreon's primary provider for apheresis services will be the American Red Cross, which has a nationwide network of apheresis centers. This resource will be augmented with other regional apheresis centers. There are more than 600 apheresis centers in the U.S., and Dendreon expects to contract with 150 to 200 of them at peak demand.
  • The Company has developed and will implement Intellivenge(TM), a first-of-its-kind advanced logistical and patient treatment management and planning system, which coordinates the patient and physician scheduling as well as the operational and logistic activities should PROVENGE be approved by the FDA. With Intellivenge, physicians and patients can log-in and track where their product is throughout the manufacturing process.
  • Dendreon's headcount is currently 290 and is expected to more than double by the anticipated time of product launch.
  • Product Pipeline

    • Dendreon plans to initiate a clinical trial of NEUVENGE(TM) (lapuleucel-T), its active cellular immunotherapy (ACI) targeting the Her2-Neu pathway in bladder cancer in late 2010 or early 2011. NEUVENGE may have applicability to multiple types of cancer including bladder, breast and colorectal cancers.
    • CA9 (carbonic anhydrase IX), which is expressed in multiple types of cancerous tissues, is being used to develop an ACI which is expected to enter Phase 1 clinical trials for metastatic renal cell carcinoma in 2011.
    • CEA (carcinoembryonic antigen) is expressed i
      '/>"/>

    SOURCE Dendreon Corporation
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Dendreon Presents Preclinical Data Demonstrating Activity of TRPM8 Agonist, D-3263, in Benign Prostatic Hyperplasia
    2. Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
    3. Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial
    4. Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
    5. Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial
    6. Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial
    7. Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October
    8. Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery
    9. Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia
    10. Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
    11. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/30/2015)... IRVINE, Calif. , July 30, 2015 /PRNewswire/ ... Novartis /Alcon executives have recently contacted the Company ... will begin as early as Monday, August 3, ... been quoted as saying that the coming electronic ... billions of dollars over the next several years.  ...
    (Date:7/30/2015)... 30, 2015  Amgen (NASDAQ: AMGN ) ... of 2015. Key results include: , Total ... of 2014 to $5,370 million, with 6 percent ... (etanercept), Prolia ® (denosumab), Sensipar ® ... ® (denosumab). Unfavorable changes in foreign exchange ...
    (Date:7/30/2015)... Ohio , July 30, 2015  Cleveland Clinic ... OMTEC® 2015 keynote address last month that industry is ... in order to gain the efficiencies—and develop the transformational ... Dr. Barsoum,s comments were preceded by Doug ... entrepreneur and OMTEC moderator, who stressed that industry must ...
    Breaking Medicine Technology:Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2
    ... Materia, Inc., a,catalyst technology company, announced today ... Co., Ltd., a leading Japanese,pharmaceutical company, for ... license agreement provides rights to discover,develop, and ... Company's catalysts and associated intellectual property., Metathesis ...
    ... Calif.--(BUSINESS WIRE)--Jun 25, 2007 - VIVUS, Inc.,(NASDAQ: ... and commercialization of novel therapeutic products,announced that ... Diabetic Patients Treated with Phentermine and Topiramate:,Outcomes ... published in the,American Diabetes Association 2007 Scientific ...
    Cached Medicine Technology:Materia Licenses Metathesis Catalyst Platform to Eisai 2VIVUS Announces Abstract Published at American Diabetes Association,Scientific Sessions 2VIVUS Announces Abstract Published at American Diabetes Association,Scientific Sessions 3
    (Date:7/31/2015)... York, NY (PRWEB) , ... July 31, 2015 , ... ... Rodgers Theatre . Those looking to catch a new and refreshing show on ... won numerous awards and achievements including an Obie Award, Outer Critics Circle Award, Drama ...
    (Date:7/31/2015)... Los Angeles, CA (PRWEB) , ... July 31, 2015 , ... ... of surgeons and cosmetic experts gathered to see if they could reach a consensus ... procedures, including breast augmentation and facelifts. Overall, the group reached 90 percent consensus on ...
    (Date:7/31/2015)... ... July 31, 2015 , ... ... pharmaceutical negligence is now available online at ( http://www.lawline.com/cle/course/its-a-wonderful-life-if-you-receive-the-right-meds-a-discussion-of-pharmaceutical-negligence ). Mr. ... approval rating from the nationwide audience. The course focused on the ...
    (Date:7/31/2015)... ... 2015 , ... As part of their company mission, Dallas pet sitting ... organizations is essential to the longevity of their business. It is for that ... Professional Pet Sitters (NAPPS) annual Presents 4 Pets supply drive. Presents 4 ...
    (Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... Transfinder, a ... 2015. , Total sales were up 16 percent year-over-year for the first six months ... Antonio Civitella said he expected Transfinder to beat last year’s record-revenue mark of $10.4 ...
    Breaking Medicine News(10 mins):Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 4Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 5Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 6Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 7Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 3Health News:Re-Broadcast of Nationally Renowned Trial Attorney Jason T. Brown's Lecture on Pharmaceutical Negligence Now Available 2Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 2Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 3Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 4Health News:Transfinder Closes First Half of 2015 with Record Revenue 2
    ... City Marathon 2007 and be Recognized for ... Runners and Avis, NEW YORK, Oct. 30 New ... today that Vincent Corso and Daniel Trush have,won the fourth-annual ... York City Marathon 2007. The award celebrates people who endeavor,to ...
    ... Conference Call and Webcast to Follow, ROCKVILLE, ... VNDA ), a biopharmaceutical company focused on the ... system disorders, today announced it will release results ... November 8, 2007, before the,market opens. A full ...
    ... a,statement of William V. Corr, executive director, Campaign ... has taken an important step,forward by recommending that ... health threats posed by secondhand smoke, while,preserving the ... as well. We,urge the Legislature to enact a ...
    ... Vote on Measure Thursday, WASHINGTON, Oct. 30 ... mouth are actually composed of 50% MERCURY, a,known neurotoxin? ... currently is not. Councilwoman Blondell Reynolds Brown wants to ... which ensures that patients are,given the opportunity to know ...
    ... preliminary, experts caution, , , TUESDAY, Oct. 30 (HealthDay News) ... a new study suggests that at least one virus ... treat some metastatic cancers. , Reporting in the ... Cancer Institute , researchers explained that the virus, Seneca ...
    ... post-traumatic stress disorder had a ,protective, effect , , TUESDAY, ... veterans suffering from depression finds that their risk factors ... other depressed Americans. , Specifically, the risk for suicide ... what,s seen in the general population. , And even ...
    Cached Medicine News:Health News:Vincent Corso and Daniel Trush Win 2007 Avis 'We Try Harder' Awards 2Health News:Vincent Corso and Daniel Trush Win 2007 Avis 'We Try Harder' Awards 3Health News:Vanda Pharmaceuticals to Announce Third Quarter 2007 Financial Results on November 8, 2007 2Health News:Indiana Legislature Should Protect All Workers from Secondhand Smoke 2Health News:A Patients Right to Know: 'Silver Fillings' are 50% Mercury 2Health News:Virus Shows Some Cancer-Killing Abilities 2Health News:Virus Shows Some Cancer-Killing Abilities 3Health News:Younger Veterans at Greater Suicide Risk 2Health News:Younger Veterans at Greater Suicide Risk 3Health News:Younger Veterans at Greater Suicide Risk 4
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    Medicine Products: